FDA Raises Concerns Over Unapproved GLP-1 Use for Weight Loss, Including Retatrutide | Retatrutide News

The FDA has raised concerns about the unapproved use of GLP-1 drugs like Retatrutide for weight loss. This emphasizes the need for regulatory oversight ...
Market News · October 11, 2026